PFF Webinar Library

fda-stamp-of-approval-and-medications

The FDA's Drug Approval Process

Fri, Sep 28, 2018

Learn about FDA requirements for drug approval, frequently used FDA terminology, and therapies for IPF.

Dr. Banu Karimi-Shah of the FDA - Center for Drug Evaluation and Research, Division of Pulmonary, Allergy, and Rheumatology Products joins us to give background information on the FDA requirements for drug approval, frequently used FDA terminology, and therapies for IPF.

Recent Webinars

  • Jun
    26
    2024

    Medications for PF

    View Webinar
  • May
    29
    2024

    Pulmonary Fibrosis and Pulmonary Rehabilitation: Exercise, Education, and Empowerment

    View Webinar
  • Bad weather
    Feb
    21
    2024

    Emergency Preparedness and PF: What You Need to Know

    This webinar will cover the risks associated with certain emergencies for pulmonary fibrosis patients and what guidelines to follow to be best prepared in case of an emergency!
    View Webinar
  • Oct
    25
    2023

    COVID-19 & Pulmonary Fibrosis: Updates & Insights

    Join us for The next installment of the PFF Disease Education Webinar Series will take place on Wednesday, October 25 at noon CT.
    View Webinar